Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
185.00
-2.40 (-1.28%)
At close: Apr 28, 2026, 4:00 PM EDT
185.10
+0.10 (0.05%)
After-hours: Apr 28, 2026, 7:28 PM EDT

Axsome Therapeutics Statistics

Total Valuation

AXSM has a market cap or net worth of $9.46 billion. The enterprise value is $9.36 billion.

Market Cap 9.46B
Enterprise Value 9.36B

Important Dates

The next confirmed earnings date is Monday, May 4, 2026, before market open.

Earnings Date May 4, 2026
Ex-Dividend Date n/a

Share Statistics

AXSM has 51.15 million shares outstanding. The number of shares has increased by 3.83% in one year.

Current Share Class 51.15M
Shares Outstanding 51.15M
Shares Change (YoY) +3.83%
Shares Change (QoQ) +1.22%
Owned by Insiders (%) 1.11%
Owned by Institutions (%) 76.32%
Float 43.24M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 14.83
Forward PS 9.40
PB Ratio 106.65
P/TBV Ratio 264.91
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 14.66
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.55, with a Debt / Equity ratio of 2.47.

Current Ratio 1.55
Quick Ratio 1.44
Debt / Equity 2.47
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -10.63

Financial Efficiency

Return on equity (ROE) is -252.11% and return on invested capital (ROIC) is -38.02%.

Return on Equity (ROE) -252.11%
Return on Assets (ROA) -16.81%
Return on Invested Capital (ROIC) -38.02%
Return on Capital Employed (ROCE) -54.42%
Weighted Average Cost of Capital (WACC) 6.83%
Revenue Per Employee $690,266
Profits Per Employee -$198,026
Employee Count 925
Asset Turnover 1.01
Inventory Turnover 2.17

Taxes

Income Tax -530,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +74.09% in the last 52 weeks. The beta is 0.47, so AXSM's price volatility has been lower than the market average.

Beta (5Y) 0.47
52-Week Price Change +74.09%
50-Day Moving Average 170.83
200-Day Moving Average 146.24
Relative Strength Index (RSI) 59.53
Average Volume (20 Days) 608,679

Short Selling Information

The latest short interest is 2.68 million, so 5.24% of the outstanding shares have been sold short.

Short Interest 2.68M
Short Previous Month 2.83M
Short % of Shares Out 5.24%
Short % of Float 6.19%
Short Ratio (days to cover) 4.54

Income Statement

In the last 12 months, AXSM had revenue of $638.50 million and -$183.17 million in losses. Loss per share was -$3.68.

Revenue 638.50M
Gross Profit 591.02M
Operating Income -169.24M
Pretax Income -183.70M
Net Income -183.17M
EBITDA -160.17M
EBIT -169.24M
Loss Per Share -$3.68
Full Income Statement

Balance Sheet

The company has $322.93 million in cash and $218.11 million in debt, giving a net cash position of $104.82 million or $2.05 per share.

Cash & Cash Equivalents 322.93M
Total Debt 218.11M
Net Cash 104.82M
Net Cash Per Share $2.05
Equity (Book Value) 88.30M
Book Value Per Share 1.74
Working Capital 210.15M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$93.41 million and capital expenditures -$480,000, giving a free cash flow of -$93.89 million.

Operating Cash Flow -93.41M
Capital Expenditures -480,000
Depreciation & Amortization 9.06M
Net Borrowing -4.11M
Free Cash Flow -93.89M
FCF Per Share -$1.84
Full Cash Flow Statement

Margins

Gross margin is 92.56%, with operating and profit margins of -26.51% and -28.69%.

Gross Margin 92.56%
Operating Margin -26.51%
Pretax Margin -28.77%
Profit Margin -28.69%
EBITDA Margin -25.09%
EBIT Margin -26.51%
FCF Margin n/a

Dividends & Yields

AXSM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.83%
Shareholder Yield -3.83%
Earnings Yield -1.93%
FCF Yield -0.99%

Analyst Forecast

The average price target for AXSM is $211.12, which is 14.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target $211.12
Price Target Difference 14.12%
Analyst Consensus Strong Buy
Analyst Count 17
Revenue Growth Forecast (5Y) 26.96%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

AXSM has an Altman Z-Score of 3.67 and a Piotroski F-Score of 4.

Altman Z-Score 3.67
Piotroski F-Score 4